TY - JOUR
T1 - Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C
AU - Miyaguchi, S.
AU - Saito, H.
AU - Ebinuma, H.
AU - Morizane, T.
AU - Ishii, H.
PY - 1997/1/1
Y1 - 1997/1/1
N2 - Correlation between the major histocompatibility complex class I antigens (HLA-A, -B and -C) and the elimination from serum of hepatitis C virus in patients with chronic hepatitis C has not been understood. We analyzed HLA phenotypes and their relationship to the efficacy of interferon treatment. Of the 172 patients who were treated with 9 million units of interferon-α2a three times a week for 6 months, 54 patients were responders and 118 patients were non-responders. No significant difference was observed between the 172 patients and 199 healthy subjects with regard to the frequencies of HLA-A, -B and -C antigen phenotypes. However, HLA-B55, B62, CW3 and CW4 frequencies were significantly higher in responders than in non-responders to the interferon treatment, CW4 was found to link with B62, but other phenotypes were independent each other. Patients with HLA B55, B62 and CW3 had a significantly lower viral load, and showed a better response to interferon. These results suggest that HLA system does not have an influence on the evolution towards chronicity of the disease due to hepatitis C virus, but HLA B55, B62 or CW4, and CW3 may be a virus quantity-regulating factors which then affect to response to the interferon treatment, indicating that these HLA antigens in conjunction with a viral peptide is a key target antigen for cytotoxic T lymphocytes in patients with chronic hepatitis C.
AB - Correlation between the major histocompatibility complex class I antigens (HLA-A, -B and -C) and the elimination from serum of hepatitis C virus in patients with chronic hepatitis C has not been understood. We analyzed HLA phenotypes and their relationship to the efficacy of interferon treatment. Of the 172 patients who were treated with 9 million units of interferon-α2a three times a week for 6 months, 54 patients were responders and 118 patients were non-responders. No significant difference was observed between the 172 patients and 199 healthy subjects with regard to the frequencies of HLA-A, -B and -C antigen phenotypes. However, HLA-B55, B62, CW3 and CW4 frequencies were significantly higher in responders than in non-responders to the interferon treatment, CW4 was found to link with B62, but other phenotypes were independent each other. Patients with HLA B55, B62 and CW3 had a significantly lower viral load, and showed a better response to interferon. These results suggest that HLA system does not have an influence on the evolution towards chronicity of the disease due to hepatitis C virus, but HLA B55, B62 or CW4, and CW3 may be a virus quantity-regulating factors which then affect to response to the interferon treatment, indicating that these HLA antigens in conjunction with a viral peptide is a key target antigen for cytotoxic T lymphocytes in patients with chronic hepatitis C.
KW - Chronic hepatitis C
KW - Cytotoxic T cell
KW - HLA
KW - Interferon
KW - Response to treatment
UR - http://www.scopus.com/inward/record.url?scp=0030969984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030969984&partnerID=8YFLogxK
U2 - 10.1111/j.1399-0039.1997.tb02808.x
DO - 10.1111/j.1399-0039.1997.tb02808.x
M3 - Article
C2 - 9234482
AN - SCOPUS:0030969984
SN - 2059-2302
VL - 49
SP - 605
EP - 611
JO - HLA
JF - HLA
IS - 6
ER -
